BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32418311)

  • 1. In vitro susceptibility of Aspergillus and Fusarium associated with equine keratitis to new antifungal drugs.
    Roberts D; Cotter HVT; Cubeta M; Gilger BC
    Vet Ophthalmol; 2020 Sep; 23(5):918-922. PubMed ID: 32418311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-locus DNA sequence analysis, antifungal agent susceptibility, and fungal keratitis outcome in horses from Southeastern United States.
    Cullen M; Jacob ME; Cornish V; VanderSchel IQ; Cotter HVT; Cubeta MA; Carbone I; Gilger BC
    PLoS One; 2019; 14(3):e0214214. PubMed ID: 30921394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
    Pearce JW; Giuliano EA; Moore CP
    Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of fungal species cultured on outcome in horses with fungal keratitis.
    Sherman AB; Clode AB; Gilger BC
    Vet Ophthalmol; 2017 Mar; 20(2):140-146. PubMed ID: 27061354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis.
    Martinez PS; Whitley RD; Plummer CE; Richardson RL; Hamor RE; Wellehan JFX
    Vet Ophthalmol; 2022 Sep; 25(5):376-384. PubMed ID: 35684950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis.
    Todokoro D; Suzuki T; Tamura T; Makimura K; Yamaguchi H; Inagaki K; Akiyama H
    Cornea; 2019 Feb; 38(2):238-242. PubMed ID: 30422866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis.
    Weinstein WL; Moore PA; Sanchez S; Dietrich UM; Wooley RE; Ritchie BW
    Am J Vet Res; 2006 Apr; 67(4):562-8. PubMed ID: 16579746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of
    Manikandan P; Abdel-Hadi A; Randhir Babu Singh Y; Revathi R; Anita R; Banawas S; Bin Dukhyil AA; Alshehri B; Shobana CS; Panneer Selvam K; Narendran V
    Biomed Res Int; 2019; 2019():6395840. PubMed ID: 30800674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.
    Shobana CS; Mythili A; Homa M; Galgóczy L; Priya R; Babu Singh YR; Panneerselvam K; Vágvölgyi C; Kredics L; Narendran V; Manikandan P
    J Mycol Med; 2015 Mar; 25(1):44-9. PubMed ID: 25541256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.
    Iqbal NJ; Boey A; Park BJ; Brandt ME
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):348-50. PubMed ID: 18707841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.
    Wang L; Wang L; Han L; Yin W
    Curr Eye Res; 2015; 40(11):1095-101. PubMed ID: 26268399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
    Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
    Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo confocal microscopy of equine fungal keratitis.
    Ledbetter EC; Irby NL; Kim SG
    Vet Ophthalmol; 2011 Jan; 14(1):1-9. PubMed ID: 21199274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atovaquone Impairs Growth of Aspergillus and Fusarium Keratitis Isolates by Modulating Mitochondrial Function and Zinc Homeostasis.
    Clark HL; Minns MS; Sun Y; de Jesus T; Ghannoum MG; Pearlman E
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1589-1598. PubMed ID: 29625485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of systemic voriconazole in equine keratomycosis based on pharmacokinetic-pharmacodynamic analysis of tear fluid following oral administration.
    Tamura N; Okano A; Kuroda T; Niwa H; Kusano K; Matsuda Y; Fukuda K; Mita H; Nagata S
    Vet Ophthalmol; 2020 Jul; 23(4):640-647. PubMed ID: 32383526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luliconazole, a highly effective imidazole, against Fusarium species complexes.
    Gharaghani M; Hivary S; Taghipour S; Zarei-Mahmoudabadi A
    Med Microbiol Immunol; 2020 Oct; 209(5):603-612. PubMed ID: 32253502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    Marangon FB; Miller D; Giaconi JA; Alfonso EC
    Am J Ophthalmol; 2004 May; 137(5):820-5. PubMed ID: 15126145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of antibiotics against Fusarium and Aspergillus.
    Day S; Lalitha P; Haug S; Fothergill AW; Cevallos V; Vijayakumar R; Prajna NV; Acharya NR; McLeod SD; Lietman TM
    Br J Ophthalmol; 2009 Jan; 93(1):116-9. PubMed ID: 18952649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro synergy of natamycin and voriconazole against clinical isolates of
    Sradhanjali S; Yein B; Sharma S; Das S
    Br J Ophthalmol; 2018 Jan; 102(1):142-145. PubMed ID: 28982951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.